ArticlePediatric research2026
Co-exposure to cannabinoids and nicotine increases senescence in prenatal human lung development.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTandem use of cigarettes and cannabis is increasing, particularly where recreational marijuana is legalized, posing a serious risk to fetal development. This study investigates the impact of cannabinoids (THC and CBD) and nicotine on fetal lung development using human lung explants from 10-16 weeks of gestation. Our results show that THC promotes epithelial cysting
resultsOur data revealed decreased proliferation (Ki-67) following treatment with CBD and CBD + THC+nicotine, whereas smooth muscle cell differentiation decreased across all conditions. Furthermore, the combination treatments induced a senescence-like phenotype as demonstrated by increased CDKN1A and CDKN2A expression and a strong reduction in LAMIN B1 staining. Additionally, DNA damage response markers ɣH2A.X and 53BP1 were significantly upregulated in the combination treatments. This was accompanied by an activation of the interferon pathway with increased expression of the downstream targets MX1 and IFI2. The addition of senolytics, Dasatinib and Quercetin (D + Q), reduced the senescence-associated secretory phenotype (SASP), such as IL-6, IL-8, M-CSF, MCP-3, MIP-1β, TNFα, MIP-3β, and TSLP, the senescence gene expressions, and reversed interferon pathway activation
conclusionOur results demonstrate that co-exposure to nicotine and cannabis alters cellular proliferation and differentiation, induces a senescence-like phenotype and DNA damage response in human fetal lung cultures, which may be partially rescued using senolytics. IMPACT: This study aims to assess the effect of cannabis and nicotine use during pregnancy on fetal human lung development. The combinatorial exposure to CBD, THC, and nicotine during pregnancy increases senescence-like phenotype, DNA damage response, and senescence-associated secretory phenotypes (SASP) secretion. The use of senolytics (D + Q) may prove to be a promising therapeutic option, alleviating several of the adverse effects induced by the different substances.
Identifiers
42414534What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.